NCT02453932View on ClinicalTrials.gov

Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia

PHASE3CompletedINTERVENTIONAL
Enrollment

543

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Vascular Dementia
Interventions
DRUG

Tianzhi granule and placebo identified to donepezil

1 pack Tianzhi granule (5g), 3 times per day and placebo identified to donepezil, 1 pill per day for 24 weeks

DRUG

Donepezil and placebo identified to Tianzhi granule

donepezil 5mg per day and placebo identified to Tianzhi granule (5g, 3 times per day) for 24 weeks

DRUG

Placebo

placebo identified to Tianzhi granule (5g, 3 times per day) and placebo identified to donepezil ,1 pills per day for 24 weeks

Trial Locations (1)

100700

Dongzhimen Hospital,Beijing University of Chinese Medicine, Beijing

All Listed Sponsors
lead

Dongzhimen Hospital, Beijing

OTHER

NCT02453932 - Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia | Biotech Hunter | Biotech Hunter